The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 751.00
Bid: 751.00
Ask: 753.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.266%)
Open: 710.00
High: 762.00
Low: 710.00
Prev. Close: 751.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 Feb 2010 07:00

RNS Number : 5762G
Acal PLC
03 February 2010
 



 

FOR RELEASE

7.00 AM

03 February 2010

 

 

ACAL plc

("Acal" or "the Group")

 

SECOND INTERIM MANAGEMENT STATEMENT

PERIOD COMMENCING 1 OCTOBER 2009

 DIRECTORATE CHANGE

 

Acal plc, a specialist provider of technology products and services across Europe and South Africa, is today issuing its second Interim Management Statement for the year ending 31 March 2010, which covers the period commencing 1 October 2009 to date and includes the quarter ended 31 December 2009.

 

The Board is pleased to report that since September 2009, trading has improved with the Group now operating profitably. The Group's balance sheet remains robust with a net cash position.

 

Electronics

 

The backlog of orders has increased at a better rate than expected, being 16% higher than the low point of April 2009, and 3% higher year on year (on a consistent basis, unadjusted for currency exchange rate movements). This is starting to translate into improved sales, which in January were around 8% higher than the previous quarter's monthly average. Orders received in the months of December and January continued at the improved level and with a positive book to bill ratio. We expect the improving sales rate to continue throughout the second half.

 

BFi Optilas ("BFi") is seeing a similar improvement. 

Supply Chain and Medical

 

As indicated in the interim results, the Supply Chain division will disengage from a major customer contract at the end of the financial year. As previously stated, losses on this contract have already been eliminated. Underlying Supply Chain sales remain stable although margins are coming under pressure.

 

Trading in the Medical division also remains stable, with sales having increased year on year. As indicated in our interim statement, spending within our UK customers in the NHS has increased in the second half of the year, although we remain cautious for the remainder of the year, as speculation of further spending cut backs continues.

 

The following material events or transactions impacted the Group during the period covered by this interim management statement.

 

Acquisition of BFi

 

On 18 December, the Group completed the acquisition of BFi for a consideration of €10 million and the issue of 2 million Ordinary Shares. The acquisition has doubled the Group's electronic sales which now account for around 70% of Group sales.

 

BFi has already exceeded our expectations in the initial period of ownership, and the process of integrating its operations with the rest of the division is progressing well.

 

Purchase and Leaseback of offices and warehouse in Eindhoven

On 31 December 2009, the Group completed the purchase, sale and leaseback of its offices and warehouse in Eindhoven. This generated a cash inflow of €0.6 million with the profit on sale being amortised over the life of the revised lease agreement.

 

Directorate Change

 

The Group also announces today that Malcolm Cooper, Group Finance Director, has resigned for personal reasons with immediate effect. Until a permanent replacement is found, Paul Neville, Group Commercial Director, will be acting Group Finance Director.

  

Nick Jefferies, Chief Executive Officer commented:

 

"The return to profitability has been achieved by taking decisive actions to reduce operating expenses and increase gross margins. Improving sales trends are now also starting to take effect. We continue to manage the business tightly, and are cautiously optimistic of a sustained improvement in market conditions.

 

We are very pleased to welcome BFi Optilas to the Acal group and are focussedon delivering the significant synergies as we build Europe's leading specialist Electronics and Photonics distributor.

 

I would like to thank Malcolm Cooper for his valuable contribution to Acal over the last ten years, and wish him well for the future."

 

 

For further information:-

 

Nicholas Jefferies ~ Chief Executive

Paul Neville ~ Group Commercial Director

 

Chris Lane / James Verstringhe

Cubitt Consulting

 

01483 544500

01483 544500

 

020 7367 5100

 

 

Notes to the Interim Management Statement

 

(a) This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Acal plc, as a body, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules.

 

Notes to Editors:

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three Divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic products to industrial manufacturing and design companies. The Supply Chain Division supplies new and refurbished IT, EPOS and ATM spare parts to service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRGDDUXGBGGD
Date   Source Headline
4th Dec 20187:00 amRNSHalf-year Report
17th Oct 20187:00 amRNSAcquisition
11th Oct 20187:00 amRNSTrading Update
10th Sep 20183:17 pmRNSIssue of Equity
22nd Aug 201811:30 amRNSHolding(s) in Company
26th Jul 20182:45 pmRNSResult of General Meeting
26th Jul 20182:40 pmRNSResult of AGM
26th Jul 20187:00 amRNSTrading Update
11th Jul 20182:17 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPublication of Circular and Notice of EGM
26th Jun 20184:46 pmRNSAnnual Report and Accounts
19th Jun 20183:03 pmRNSIssue of Equity
11th Jun 201810:56 amRNSHolding(s) in Company
7th Jun 20184:08 pmRNSDirector/PDMR Shareholding
6th Jun 20189:00 amRNSExercise of share options
5th Jun 20187:00 amRNSFinal Results
19th Apr 20187:00 amRNSTrading Update
29th Mar 20182:15 pmRNSDirector/PDMR Shareholding
27th Mar 20182:41 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSNotice of Capital Markets Day
5th Mar 201810:26 amRNSDirector/PDMR Shareholding
21st Feb 20189:15 amRNSIssue of Equity
9th Feb 201812:11 pmRNSDirector/PDMR Shareholding
2nd Feb 20182:48 pmRNSTotal Voting Rights
1st Feb 20187:00 amRNSAcquisition
31st Jan 20187:00 amRNSTrading Update
23rd Jan 20187:00 amRNSDirectorate Change
29th Nov 20178:01 amRNSChange of Name
28th Nov 20179:06 amRNSHolding(s) in Company
28th Nov 20177:01 amRNSChange of Name
28th Nov 20177:00 amRNSHalf-year Report
16th Oct 20177:00 amRNSTrading Update
11th Oct 20175:25 pmRNSHolding(s) in Company
19th Sep 20175:04 pmRNSHolding(s) in Company
14th Sep 20177:00 amRNSSector Reclassification
13th Sep 201710:36 amRNSNotification of Change of Auditor
17th Aug 20172:33 pmRNSHolding(s) in Company
15th Aug 201711:32 amRNSDirector/PDMR Shareholding
4th Aug 201710:00 amRNSEXERCISE OF SHARE OPTION
3rd Aug 20174:30 pmRNSHolding(s) in Company
25th Jul 20173:47 pmRNSResult of AGM
25th Jul 20177:00 amRNSTrading Update
26th Jun 201710:38 amRNSAnnual Report and Accounts
21st Jun 20174:57 pmRNSHolding(s) in Company
13th Jun 201710:15 amRNSHolding(s) in Company
6th Jun 20177:00 amRNSFinal Results
19th Apr 20177:00 amRNSTrading Update
13th Apr 201712:34 pmRNSDirector/PDMR Shareholding
12th Apr 20178:50 amRNSHolding(s) in Company
4th Apr 20174:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.